$AX insiders have traded $AX stock on the open market 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales. Here’s a breakdown ...
ProQR is developing RNA therapies based on its proprietary Axiomer RNA editing technology platform. The ongoing Phase 1 study of AX-0810, which targets NTCP for cholestatic diseases such as primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback